nebicapone
Small moleculeexperimental
Clinical trial activity
10 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
9
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2000 (NCT02763787)
Timeline
Indications
Mechanism of action
- Catechol O-methyltransferaseINHIBITOR
COMT inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
O=C(Cc1ccccc1)c1cc(O)c(O)c([N+](=O)[O-])c1- Mol. weight
- 273.24 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL160038 ↗
Also known as
- 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone
- bia 3-202
- bia 3-202
- bia 3-202
- nebicapone
- nebicapone
- nebicapone
- nebicapone
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02779348 | Phase 1 | Sep 1, 2006 | Bial |
| NCT02772614 | Phase 1 | Jan 1, 2006 | Bial |
| NCT02774564 | Phase 1 | Sep 1, 2005 | Bial |
| NCT02778594 | Phase 1 | Sep 1, 2005 | Bial |
| NCT02834507 | Phase 2 | Mar 1, 2005 | Bial |
| NCT02772627 | Phase 1 | Sep 1, 2001 | Bial |
| NCT02763852 | Phase 1 | Apr 1, 2001 | Bial |
| NCT02763839 | Phase 1 | Apr 1, 2001 | Bial |
| NCT02763800 | Phase 1 | Sep 1, 2000 | Bial |
| NCT02763787 | Phase 1 | Apr 1, 2000 | Bial |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bial | For profit | 10 | 10 | 2 | 2000 |
1 organizations
Page 1 / 1